Ayad Abrou, MD
MOHS-Micrographic Surgery · Rochester Hills, MINPI 1457305815
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 144 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$441
- E.r. Squibb & Sons, L.L.C.$277
- Johnson & Johnson$227
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$202
- Novartis$183
- Sanofi$181
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,67092%
- Education$2268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $441 |
| E.r. Squibb & Sons, L.L.C. | 18 | $277 |
| Johnson & Johnson | 8 | $227 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $202 |
| Novartis | 10 | $183 |
| Sanofi | 8 | $181 |
| Sun Pharmaceutical Industries Inc. | 5 | $169 |
| Pfizer | 8 | $146 |
| Incyte Corporation | 5 | $112 |
| Galderma Laboratories, L.p. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 6 | $92 |
| Dermavant Sciences, Inc. | 4 | $83 |
| Novo Nordisk | 1 | $83 |
| Genentech USA, Inc. | 5 | $80 |
| UCB, Inc. | 3 | $76 |
| Lilly USA, LLC | 4 | $70 |
| Kerecis Limited | 2 | $59 |
| Amgen | 3 | $54 |
| Organon | 2 | $47 |
| LEO Pharma Inc. | 2 | $34 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| Almirall LLC | 1 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Journey Medical Corporation | 1 | $23 |
| Organogenesis Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| EPI Health, LLC | 1 | $14 |
How this compares
$2,896 in reported general payments places this provider in the 65th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 24 | $91,263 |
| Mupirocin | 2,300 | $14,912 |
| Tacrolimus | 77 | $11,164 |
| Metronidazole | 234 | $10,624 |
| Clobetasol Propionate | 182 | $10,167 |
| Ciclopirox | 275 | $8,043 |
| Calcipotriene | 28 | $6,584 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 318 | $5,083 |
| Fluocinonide | 185 | $4,960 |
| Clindamycin Phosphate | 124 | $4,199 |
| Ketoconazole | 193 | $3,854 |
| CiclopiroxCiclopirox Olamine | 144 | $3,391 |
| Triamcinolone Acetonide | 309 | $3,098 |
| Gentamicin Sulfate | 73 | $2,521 |
| Ivermectin | 12 | $2,422 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Rochester Hills
- David ByrdRochester Hills$10K
- Bryan SofenRoyal Oak$35K
- David OzogDetroit$22K
- Michael WhitworthWyandotte$13K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
- Syed HamzaviClinton Twp$4K
- Aaron CetnerWest Bloomfield$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.